From: Modeling-based design of adaptive control strategy for the effective preparation of ‘Disease X’
Easing time | Dominant variant | Transmission rate \(\beta\) | Death rate \(d\) | Setting of initial conditions \({S}^{i,j,0}\left(0\right)\) | |
---|---|---|---|---|---|
Baseline | 2022–11-1 | Omicron | \({\beta }_{0}\) | \({d}_{0}\) | \(\left[\begin{array}{ccc}\begin{array}{c}26400286\\ 0\end{array}& \begin{array}{c}55040710\\ 1018336977\end{array}& \begin{array}{c}24724860\\ 206101342\end{array}\\ 0& 9528481& 12833072\\ 0& 38470686& 20343586\end{array}\right]\) |
Scenario 1 | 2021–6-1 | Delta | \(\frac{{R}_{\delta }}{{R}_{0}}*{\beta }_{0}\) | \(3*{d}_{0}\) | \(\left[\begin{array}{ccc}26400286& 623139507& 146704126\\ 0& 498237346& 117298733\\ \begin{array}{c}0\\ 0\end{array}& \begin{array}{c}0\\ 0\end{array}& \begin{array}{c}0\\ 0\end{array}\end{array}\right]\) |
Scenario 2 | 2022–1-1 | Omicron | \({\beta }_{0}\) | \({d}_{0}\) | \(\left[\begin{array}{ccc}26400286& 110046459& 25907954\\ 0& 39996117& 9416182\\ \begin{array}{c}0\\ 0\end{array}& \begin{array}{c}971334276\\ 0\end{array}& \begin{array}{c}228678723\\ 0\end{array}\end{array}\right]\) |